Latest news
-
-
- Rachel Savery appointed interim Managing Director of Cardiff Health Partners
-
Cardiff Health Partners (CHP), a strategic partnership between Cardiff University, Cardiff and Vale University Health Board and Velindre University NHS Trust, has appointed Rachel Savery as its interim Managing Director.
-
-
- Major investment in groundbreaking programme to speed up cancer diagnosis in Wales
-
A major £2.52 million investment will accelerate the use of cutting-edge liquid biopsy technology that analyses cancer DNA from a blood sample, supporting faster and more personalised treatment decisions.
-
-
- Chief Pharmacist becomes Royal Pharmaceutical Society Fellow
-
We are delighted to share the fantastic news that our Chief Pharmacist, Bethan Tranter, has been designated a Fellow of the Royal Pharmaceutical Society – one of the highest honours in the profession.
-
-
- Chief Medical Officer for Wales visits Velindre
-
Velindre University NHS Trust was pleased to welcome the Chief Medical Officer for Wales for a visit that provided a comprehensive look at the broad work across the Trust and the progress being made on the new Velindre Cancer Centre.
-
-
- Celebrating success at the MediWales Innovation Awards
-
Velindre Cancer Service colleagues have been recognised for their outstanding contributions to healthcare innovation at last week’s MediWales Innovation Awards.
-
-
- First patient recruited in clinical trial using cancer-targeting virus
-
Accession Therapeutics’ ATTEST trial is a first-in-human Phase 1 trial in solid tumour patients, testing TROCEPT-01 (also known as ATTR-01). The trial is being delivered by Velindre University NHS Trust and Cardiff and Vale University Health Board.
Velindre University NHS Trust, Unit 2,Charnwood Court, Parc Nantgarw, Nantgarw, Cardiff, CF15 7QZ
Tel: 029 2019 6161
